Physician profile
Andrew E Krupitsky
NPI 1104936798
$6,847.16
in general payments reported to CMS, 2019-2025
44 companies · $974 in 2025
The $974 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,627 · 2020: $582 · 2021: $699 · 2022: $1,059 · 2023: $713 · 2024: $1,192 · 2025: $974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,879.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $933.17 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $802.80 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $641.83 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $569.71 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $536.27 | 2019-2025 | |
| Abbvie INC. | $497.22 | 2019-2024 | |
| Glaxosmithkline, LLC. | $423.37 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $281.09 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Exact Sciences Corporation | $204.40 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $198.39 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Xeris Pharmaceuticals, INC. | $162.75 | 2021-2025 | Keveyis, Recorlev |
| Novartis Pharmaceuticals Corporation | $127.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $125.16 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Alkermes, INC. | $125.00 | 2019 | |
| Allergan, INC. | $114.04 | 2019-2020 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Krupitsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.